Literature DB >> 25866041

Safety guideline: reducing the risk from cemented hemiarthroplasty for hip fracture 2015: Association of Anaesthetists of Great Britain and Ireland British Orthopaedic Association British Geriatric Society.

R Griffiths, S M White, I K Moppett, M J Parker, T J S Chesser, M L Costa, A Johansen, H Wilson, A J Timperley.   

Abstract

Concise guidelines are presented for the preparation and conduct of anaesthesia and surgery in patients undergoing cemented hemiarthroplasty for hip fracture. The Working Party specifically considered recent publications highlighting complications occurring during the peri-operative period. The advice presented is based on previously published advice and clinical studies.
© 2015 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25866041      PMCID: PMC6681143          DOI: 10.1111/anae.13036

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


What other guideline statements are available on this topic?
The National Patient Safety Agency (NPSA) issued an alert in 2009, about the use of bone cement during hip arthroplasty 3. Specialty‐focused advice has been published by both anaesthetists 4 and surgeons 5. Why was this guideline developed?
The Anaesthesia Sprint Audit of Practice (ASAP) 1 collected prospective information on bone cement implantation syndrome (BCIS) 6. The audit revealed evidence of cardiovascular compromise in some patients undergoing cemented hemiarthroplasty for hip fracture. How does this statement differ from existing guidelines?
This document has been a collaborative effort by anaesthetists, surgeons and orthogeriatricians. It highlights the need for joint decision making, teamworking and attention to detail during the peri‐operative period. Why does this statement differ from existing guidelines?
This is the first multidisciplinary clinical guidance on peri‐operative management of this clinical problem.

Recommendations

There should be a three‐stage process to reduce the incidence of problems in patients undergoing cemented hemiarthroplasty for hip fracture: Identification of patients at high risk of cardiorespiratory compromise: Increasing age; Significant cardiopulmonary disease; Diuretics; Male sex. Preparation of team(s) and identification of roles in case of severe reaction: Pre‐operative multidisciplinary discussion when appropriate; Pre‐list briefing and World Health Organization Safe Surgery checklist ‘time‐out’. Specific intra‐operative roles: Surgeon: Inform the anaesthetist that you are about to insert cement; Thoroughly wash and dry the femoral canal; Apply cement in retrograde fashion using the cement gun with a suction catheter and intramedullary plug in the femoral shaft; Avoid vigorous pressurisation of cement in patients judged to be at risk of cardiovascular compromise (see below). Anaesthetist: Ensure adequate resuscitation pre‐ and intra‐operatively; Confirm to surgeon that you are aware that he/she is about to prepare/apply cement; Maintain vigilance for signs of cardiorespiratory compromise. Use either an arterial line or non‐invasive automated blood pressure monitoring set on the ‘stat’ mode during/shortly after application of cement. Early warning of cardiovascular collapse may be heralded by a drop in systolic pressure. During general anaesthetic, a sudden drop in end‐tidal pCO2 may indicate right heart failure and/or catastrophic reduction in cardiac output; Aim for a systolic blood pressure within 20% of pre‐induction value; Prepare vasopressors in case of cardiovascular collapse.

Introduction

This guidance is aimed at clinicians involved in the intra‐operative management of patients undergoing cemented arthroplasty. The guidance does not include the consenting process, or the choice of surgical intervention, which is covered in existing national guidelines 7, although the Working Party acknowledges that these are vital parts of the process by which patients undergo such surgery, and that the usual requirements for individualised treatment and supplying patients with appropriate information must apply.

Bone cement implantation syndrome

Surgical instrumentation of the femoral canal has been associated with significant cardiovascular compromise 1, 5. This phenomenon can occur with any such surgery, especially procedures that breach the femoral canal, such as intramedullary nailing and cemented and uncemented hip implants, but the risk has been particularly highlighted in frail patients undergoing cemented hemiarthroplasty following hip fracture. During surgery, significant cardiovascular compromise can occur during preparation of the femoral canal, during insertion of the cement (if used for fixation) and/or prosthesis, and when the hip is reduced 6. Compared with uncemented prostheses, the use of cemented prostheses for hip fracture surgery increases the likelihood of pain‐free mobility after surgery 8, reduces the risk of re‐operation and is associated with a lower mortality rate at 30 days 8, 9, 10, 11. However, an adverse cardiovascular event has been associated with cemented hemiarthroplasty and this is sometimes referred to as ‘bone cement implantation syndrome’ (BCIS) 6. Adverse cardiovascular events occur in approximately 20% of hip fracture operations in which a cemented prosthesis is used 1, 2. The severity of the reaction is indicated in Table 1.
Table 1

Incidence of adverse effects during arthroplasty using a cemented prosthesis 1, 2.

Grade 1Arterial saturation < 94% or > 20% fall in systolic blood pressure~20%
Grade 2Arterial saturation < 88% or hypotension > 40% fall in systolic blood pressure or loss of consciousness~3%
Grade 3Cardiopulmonary resuscitation required~1%
Incidence of adverse effects during arthroplasty using a cemented prosthesis 1, 2. Certain patient factors are associated with an increased risk of severe cardiovascular events during cemented hemiarthroplasty, in particular increasing age, male sex, significant cardiopulmonary disease and use of diuretic medication 2, 11. These factors are also associated with increased 30‐day mortality, though the magnitude of the association is far greater for BCIS itself 2.

Administrative and human factor aspects

In patients with the above risk factors, discussion between surgeons, anaesthetists and orthogeriatricians should consider how best to minimise the early peri‐operative risks of mortality and morbidity, given the known benefits of surgical intervention 10. Surgeons and anaesthetists can also modify peri‐operative practice both to reduce the risk of cardiovascular events and to improve outcome in the event of such an event (Table 2) 11. All hip fracture surgery should be undertaken or directly supervised by appropriately experienced anaesthetists and surgeons and on planned trauma lists 7.
Table 2

Specific intra‐operative surgical and anaesthetic roles for reducing the incidence and management of BCIS.

Conduct of surgery Ask the anaesthetist to confirm that he/she has heard your instruction to the theatre team that you are about to prepare the femoral canal for cement and prosthesis insertion Carefully prepare, wash and dry the femoral canal. Use of a pressurised lavage system is recommended to clean the endosteal bone of fat and marrow contents Use a distal suction catheter on top of an intramedullary plug. Insert the cement from a gun in retrograde fashion on top of the plug and pull the catheter out as soon as it is blocked with cement. Do not use excessive manual pressurisation or pressurisation devices in patients at higher risk of cardiovascular events (see above for risk factors)
Conduct of anaesthesia Ensure that the patient is adequately hydrated before induction of and during anaesthesia Maintain vigilance for possible cardiovascular events once the femoral head is removed and the surgeon has verbally indicated his/her intent to instrument the femoral canal Confirm to the surgeon that you are aware of preparation of the femoral canal for cement and prosthesis insertion Aim to maintain the systolic blood pressure within 20% of pre‐induction values throughout surgery, using vasopressors and/or fluids. Invasive blood pressure monitoring is indicated for patients at higher risk Be ready to give vasopressors, e.g. metaraminol/adrenaline in case of cardiovascular collapse
Specific intra‐operative surgical and anaesthetic roles for reducing the incidence and management of BCIS. All members of the theatre team should be aware of the problems associated with femoral instrumentation and the use of cemented prostheses. The potential for adverse events should be identified for each patient as part of both the pre‐list briefing before starting a theatre list and at the World Health Organization Safe Surgery checklist ‘time‐out’ immediately before surgery. In the event of a severe reaction or cardiopulmonary arrest, theatre staff should be aware of their defined roles in resuscitating the patient, as described in the Coventry ‘cement curfew’ and modified according to individual hospital operating procedures 12.
  17 in total

Review 1.  Anaesthesia for hip fracture repair.

Authors:  C Shelton; S White
Journal:  BJA Educ       Date:  2020-03-23

2.  Correction.

Authors: 
Journal:  Anaesthesia       Date:  2018-02       Impact factor: 6.955

3.  An evaluation of peri-operative clinical, serological and radiological parameters in hip arthroplasties -a prospective observational study of Indian cohorts.

Authors:  Atul Panghate; Abhinav D Jogani; Sameer Panchal; Jigar Desai; Nandan Marathe; Rajkumar Rathod
Journal:  J Orthop       Date:  2022-02-17

4.  Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: A randomized controlled trial with two years follow-up.

Authors:  Igor Movrin
Journal:  Acta Orthop Traumatol Turc       Date:  2020-01       Impact factor: 1.511

5.  How clinical registries can make a difference in hip fracture care.

Authors:  M D Neuman
Journal:  Anaesthesia       Date:  2016-03-04       Impact factor: 6.955

6.  What Are the Frequency, Related Mortality, and Factors Associated with Bone Cement Implantation Syndrome in Arthroplasty Surgery?

Authors:  Rachid Rassir; Maarten Schuiling; Inger N Sierevelt; Casper W P van der Hoeven; Peter A Nolte
Journal:  Clin Orthop Relat Res       Date:  2021-04-01       Impact factor: 4.176

7.  Reply to the Letter to the Editor: Cemented or Uncemented Hemiarthroplasty for Femoral Neck Fracture? Data from the Norwegian Hip Fracture Register.

Authors:  Torbjørn B Kristensen; Eva Dybvik; Målfrid Kristoffersen; Håvard Dale; Lars Birger Engesæter; Ove Furnes; Jan-Erik Gjertsen
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

8.  Tight intra-operative blood pressure control versus standard care for patients undergoing hip fracture repair - Hip Fracture Intervention Study for Prevention of Hypotension (HIP-HOP) trial: study protocol for a randomised controlled trial.

Authors:  Iain Keith Moppett; Stuart White; Richard Griffiths; Donal Buggy
Journal:  Trials       Date:  2017-07-25       Impact factor: 2.279

9.  Hydroxyapatite coated hip hemiarthroplasty: Morbidity and mortality.

Authors:  Muhammad Ali Fazal; Sunil Shah; Padmanabhan Subramanian
Journal:  J Clin Orthop Trauma       Date:  2020-05-08

Review 10.  Recent advances in the treatment of hip fractures in the elderly.

Authors:  Joshua C Rozell; Mark Hasenauer; Derek J Donegan; Mark Neuman
Journal:  F1000Res       Date:  2016-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.